Law360, New York (January 06, 2009, 12:00 AM ET) -- Abbott Laboratories has sued Bayer HealthCare LLC for a judgment that a Bayer patent is invalid and unenforceable, firing back at an infringement suit Bayer filed recently seeking to assert the patent against Abbott's hugely popular arthritis drug Humira.
In a complaint filed Monday in the U.S. District Court for the District of Massachusetts, Abbott asked for a declaration that Humira does not infringe U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” and that the '407 patent is invalid and unenforceable under the doctrine of laches,...
Abbott Strikes Back At Bayer Patent Suit Over Humira
To view the full article, take a free trial now.
